Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 18 von 318

Details

Autor(en) / Beteiligte
Titel
ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations
Ist Teil von
  • Journal of the American College of Cardiology, 2012-12, Vol.60 (23), p.2427-2463
Ort / Verlag
New York: Elsevier Inc
Erscheinungsjahr
2012
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Often the topic is the subject of considerable ongoing investigation. [...]the reader should view the ECD as the best attempt of the ACCF and document cosponsors to inform and guide clinical practice in areas where rigorous evidence may not yet be available or evidence to date is not widely applied to clinical practice. All participating organizations participated in peer review, resulting in 22 reviewers representing 170 comments.\n Anderson Content Reviewer--ACCF Unstable Angina Guideline BSCI/sanofi None None AstraZeneca (DSMB) Gilead Pharma (DSMB) Hamilton Health Sciences University (DSMB) Harvard (DSMB) NIH (DSMB) Toshiba Deseret Foundation, Intermountain Healthcare NIH Defendant, management of cardiopulmonary arrest post-op, 2010 Defendant, stroke after ablation for AF, 2010 James A. de Lemos Content Reviewer--ACCF Task Force on CECD Johnson & Johnson Tethys Bristol-Myers Squibb/sanofi-aventis partnership* None Bristol-Myers Squibb (DSMB) Roche Diagnostics* AstraZeneca* Daiichi Sankyo None Robert A. Guyton Content Reviewer--ACCF CABG Guideline None None None Edwards Lifesciences NIH None None Richard J. Kovacs Content Reviewer--ACCF Abbott Laboratories Biomedical Systems Cook* ECG Scanning and Medical Services* Eli Lilly* Endocyte Essentialis XenoPort None None None None None Frederick G. Kushner Content Reviewer--ACCF STEMI Guideline FDA None Bristol-Myers Squibb Merck Roche Holding* Daiichi Sankyo Hoffmann La Roche NIH Novartis FDA Science Board None David Lanfear Content Reviewer--ACCF Heart Failure and Transplant Committee Thoratec None None sanofi-aventis* Johnson & Johnson* HFSA None John F. Robb Content Reviewer--ACCF None None None None None None Sidney C. Smith, Jr. Relationships in this table are modest unless otherwise noted.AACC = American Association for Clinical Chemistry; ACCF = American College of Cardiology Foundation; ACCP = American College of Chest Physicians; ACP = American College of Physicians; AF = atrial fibrillation; AHA = American Heart Association; CABG = coronary artery bypass graft surgery; CECD = Clinical Expert Consensus Documents; DSMB = Data and Safety Monitoring Board; FDA = Food and Drug Administration; HFSA = Heart Failure Society of America; NIH = National Institutes of Health; PCI = percutaneous coronary intervention; SCAI = Society for Cardiovascular Angiography and Interventions; STEMI = ST-segment elevation myocardial infarction; UA = unstable angina.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX